Search results for Bcax

Latest updates for Bcax

Fresh curated links around BCAX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Post angles to try

Share the most useful takeaway for your audience.

Turn one article into a quick practical checklist.

Ask your audience how this shift affects their work.

Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

fool.com /2 weeks ago

Bicara (BCAX) Q1 2026 Earnings Transcript

Image source: The Motley Fool. DateMay 11, 2026, at 8:30 a.m. ETCall participantsChief Executive Officer — Claire Mazumdar ClemonChief Medical Officer — Bill SchelmanChief Commerc...

Read source

seekingalpha.com /1 week ago

Bicara Therapeutics Inc. (BCAX) Discusses New Clinical Data on Investigational Therapy for HPV Negative Head and Neck Ca...

Read source

fool.com /3 weeks ago

Bicara Therapeutics Chief Medical Officer Sells 5,500 Shares for $126,000

This Boston biotech specializing in antibody therapies for solid tumors reported a notable insider sale during active clinical development.

Read source

seekingalpha.com /2 weeks ago

ImmunityBio acquiring U.S. rights to Tokyo strain of BCG

Read source

seekingalpha.com /1 month ago

Compass Therapeutics, Inc. (CMPX) Discusses Positive Secondary Endpoint Results From COMPANION-002 Study in Advanced Bil...

Read source

cafepharma.com /1 month ago

Axonics

Axonics Anonymous (not verified) Sun, 04/05/2026 - 17:00 field_thread_url https://cafepharma.com/boards/threads/axonics.704805/ board na...

Read source

pharmexec.com /3 weeks ago

<![CDATA[UCB Enters $2.2 Billion Agreement to Acquire Candid Therapeutics ]]>

Read source

cafepharma.com /3 weeks ago

Axonics

Axonics Anonymous (not verified) Sat, 05/09/2026 - 08:22 field_thread_url https://cafepharma.com/boards/threads/axonics.704805/ board na...

Read source

finance.yahoo.com /2 weeks ago

RBC Capital Lifts PT on CG Oncology (CGON), Calls PIVOT-006 a Complex Catalyst

Read source

pharmexec.com /1 month ago

<![CDATA[Biogen Enters $5.6 Billion Agreement to Acquire Apellis Pharmaceuticals ]]>

Read source

pharmexec.com /3 weeks ago

<![CDATA[Pharmaceutical Executive Daily: UCB to Acquire Candid Therapeutics]]>

Read source

cafepharma.com /5 days ago

Beigene

Beigene Anonymous (not verified) Mon, 05/25/2026 - 11:38 field_thread_url https://cafepharma.com/boards/threads/beigene.637588/ board na...

Read source

cafepharma.com /1 month ago

Beigene

Beigene Anonymous (not verified) Thu, 04/30/2026 - 14:18 field_thread_url https://cafepharma.com/boards/threads/beigene.637588/ board na...

Read source

multiple-sclerosis-research.org /1 month ago

Frexalimab AAN20226

Frexalimab is an indirect B cell inhibitor. It block the natural signal that a B cell gets from T cells and antigen presenting cells as it blocks the ligand (binding bit) to the CD...

Read source

newswire.com /1 month ago

XCF Global, Files First Form 10 - K

Read source

qchron.com /1 month ago

Cadonilimab Combination Demonstrates Promising Survival Benefit in Locally Advanced Pancreatic Cancer: Phase II COMPASSI...

HONG KONG, April 20, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that positive Phase II results from the COMPASSION-26 study evaluating ca...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.